Lb Pharmaceuticals LBRX
NASDAQ LBRX
$37.28 -0.61 (-1.61%)
At close: Sep 29, 2026 · 4:00 PM EDT

Lb Pharmaceuticals (LBRX) Assets (2024 - 2026)

Updated

Lb Pharmaceuticals (LBRX) posted Assets of $361.69 million for Q2 2026, down 8.1% from the prior quarter.

Analysis

Lb Pharmaceuticals (LBRX) Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Lb Pharmaceuticals' Assets came in at $312.93 million, up 833.2% from FY2024.

  • In prior years, Lb Pharmaceuticals' Assets was $33.53 million in FY2024.
  • Quarterly Assets has run from a low of $33.53 million in Q4 2024 to a high of $393.48 million in Q1 2026 over five years.
  • According to Business Quant data, Assets for the three prior quarters was $393.48 million (Q1 2026), $312.93 million (Q4 2025) and $320.75 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 201.06 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 135.12 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 115.83 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 49.36 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 27.42 Bn
10 Lb Pharmaceuticals 1.09 Bn 1.09 Bn - 361.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 361.69 Mn
Mar 31, 2026 393.48 Mn
Dec 31, 2025 312.93 Mn
Sep 30, 2025 320.75 Mn
Dec 31, 2024 33.53 Mn
API Access

Lb Pharmaceuticals Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=LBRX&period=max&api_key=YOUR_API_KEY